|
⚲
|
| Vertex Pharmaceuticals Inc / Ma | |
|---|---|
| Ticker | VRTX |
| CIK # | 0000875320 |
| CUSIP | 92532F100 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 130 Waverly Street, Cambridge, MA 02139-4242 |
| Source | [EDGAR] |
| CIK | Filing | 2011 - 2024 |
|---|---|---|
| [0000875320] | 10-K | |
| [0000875320] | 10-Q | |
| [0000875320] | 3 | |
| [0000875320] | 4 | |
| [0000875320] | 5 | |
| [0000875320] | 8-K | |
| [0000875320] | SC 13D | |
| [0000875320] | SC 13G |
| Form 3/4/5 Filer | 2011 - 2024 |
|---|---|
| Ambrose Kristen | |
| Vertex Pharmaceuticals Inc / Ma | |
| Arbuckle Stuart A | |
| Sanna Bastiano |